BIOMARKERS FOR EARLY SEPSIS DETECTION
With
Dr Gabrielle Briggs
Postdoctoral Researcher and Lab Manager,
School of Medicine and Public Health
The University of Newcastle, New South Wales, Australia
RESEARCHER PROFILE
Filmed in Newcastle, New South Wales, Australia | October 2025
Dr Gabrielle Briggs is a biomedical scientist dedicated to finding smarter, faster ways to diagnose and treat life threatening complications in critically ill patients. Dr Briggs established a research laboratory embedded within the John Hunter Hospital – one of the busiest major trauma centres in NSW. Dr Briggs works alongside surgeons, intensivists, and pathologists to turn complex clinical problems into practical research solutions. Her work spans two major programs: developing a rapid diagnostic test to detect bacterial infections in blood before sepsis takes hold, and exploring mitochondrial transplantation as a novel therapy to rescue injured tissues after trauma and ischaemia.
Dr Briggs has a strong focus on innovation and translation, building close partnerships between the university and the health service to accelerate the movement of new technologies into clinical practice. Gabrielle played a key role in founding the Hunter Medical Research Institute’s Injury and Trauma Research Program and currently serves as its Deputy Director. Gabrielle is also an enthusiastic educator, teaching the next generation of clinicians in the University of Newcastle’s Joint Medical Program.
Source: Supplied
You Might also like
-
Lymphoma, Myeloma and Genomics
Professor Dipti Talaulikar is a clinical and laboratory haematologist with expertise in genomics, working at Canberra Health Services, and Professor at ANU. She has a clinical and research interest in lymphoma, myeloma and genomics, and has authored close to 100 peer reviewed papers, including several clinical guidelines that have had a significant impact on clinical practice.
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
Corneal and Ocular Surface Immunology and Regeneration
Assoc Professor Holly Chinnery’s career in ocular immunology began with a focus on animal models; however, it has recently transitioned into clinical imaging studies involving human research participants. The ability to visualise the immune system and sensory nerves in the human cornea represents a significant advantage in corneal immunology and neuroimmunology research.
https://orcid.org/0000-0002-9117-4772